North America Osteoporosis Treatment Market to Reach USD 8.29 Billion by 2027

(The Express Wire via Comtex)

The ”North America osteoporosis treatment“ market size is expected to gain momentum by reaching USD 8.29 billion by 2027 while exhibiting a CAGR of 6.6% between 2020 and 2027. This is attributable to the increasing prevalence of osteoporosis and the growing number of government approvals for the therapeutic drugs that are propelling the demand in the North America osteoporosis treatment options. Fortune Business Insights in its latest report, titled, “North America Osteoporosis Treatment Market Size, Share and Covid-19 Impact Analysis, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator (SERMs), RANK ligand (RANKL) Inhibitor, and Others), By Route of Administration (Oral, and Parenteral); By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies and Stores, and Online Pharmacies), 2020-2027.”, mentions that the market stood at USD 5.18 billion in 2019.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/sample/north-america-osteoporosis-treatment-market-104867

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations travel bans and quarantines restaurants closed all indoor events restricted over forty countries state of emergency declared massive slowing of the IT Spending market volatility falling business confidence, growing panic among the population, and uncertainty about future.

Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

COVID-19 Impact: Market to Experience a Sluggish Growth at 2.3% CAGR in 2020

The COVID-19 pandemic has led to the healthcare systems and hospitals to divert their complete focus on treating people suffering from the disease. In contrast, several elective medical procedures and osteoporosis treatment appointments have either been canceled or postponed. Based on our analysis, the market will exhibit a slow growth at 2.3% CAGR in 2020 due to the aforementioned reasons. However, the market will return to normalcy once the pandemic is over.

Osteoporosis is a type of medical condition that occurs when the bone synthesis gets interrupted and if left unattended, often may lead to a fracture. In addition to this, the condition leads to brittle and lower density of bones and is mostly common in the older population, along with women.

An Overview of the Impact of COVID-19 on this Market :

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit:https://www.fortunebusinessinsights.com/north-america-osteoporosis-treatment-market-104867

What does the Report Provide?

The market report provides an in-depth analysis of several factors such as the key drivers and restraints that will have an impact on the market. Furthermore, the report includes significant insights into the regional insights that include different regions, which are contributing to the market growth. It includes the competitive landscape involving the leading companies and the adoption of strategies by them to introduce new products, announce partnerships, collaborate, and acquire other companies that will contribute to the market growth during the forecast period. Moreover, the research analyst has adopted several research methodologies such as Porter’s five forces analysis to obtain information about the current trends and industry developments that will drive the market growth between 2020 and 2027.

DRIVING FACTORS

Increasing Incidence of Osteoporosis to Promote Growth

According to the National Institute of Health (NIH), around 10 million Americans aged 50 and older suffer from osteoporosis of the hip. The increasing prevalence of this disease that results in the deformity and fragile nature of the bones is expected to boost the demand for the market for North America osteoporosis treatment. Moreover, several companies are focusing on developing novel therapeutic solutions leading to the growing approvals by the U.S. FDA in treating osteoporosis will contribute to the North America osteoporosis treatment market growth in the forthcoming years.

Quick Buy -North America Osteoporosis Treatment MarketResearch Report:

https://www.fortunebusinessinsights.com/checkout-page/104867

SEGMENTATION

Parenteral Segment to Showcase Exponential Growth

Based on the route by administration, the parenteral segment is expected to hold a significant North America osteoporosis treatment market share due to increasing RandD activities by the healthcare companies to develop novel parenteral drugs during the forecast period.

COUNTRY INSIGHTS

Presence of Established Players in the U.S. to Feed Market Growth

Geographically, the U.S market stood at USD 4.98 billion in 2019 and is expected to hold the highest position in the North American market in the forthcoming years. This is ascribable to factors such as presence of established players such as AbbVie Inc., Pfizer Inc., and Amgen Inc. that play a pivotal role in the North America osteoporosis treatment solutions development.

The market in Canada is anticipated to experience considerable growth backed by the increasing prevalence of osteoporosis and supportive government policies to educate the people regarding therapeutic treatment solutions between 2020 and 2027.

COMPETITIVE LANDSCAPE

Collaboration between Eminent Companies to Brighten Their Market Positions

The market for North America is experiencing proactive competition between major companies that are collaborating with other companies to expand their product portfolio and boost sales revenue. Furthermore, other key players are adopting organic and inorganic strategies such as partnership, the introduction of novel products, and merger and acquisition that will bode well for the growth of the market for North America.

Industry Development:

  • August 2020- Celltrion Healthcare Co., Ltd commenced the Phase 1 trial of Denosumab Biosimilar, a monoclonal antibody injection adopted in the management of osteoporosis. The company has invested in RandD to develop novel therapeutics solutions for the treatment of the disease.

List of the Companies Profiled in the Market:

  • AbbVie Inc. (North Chicago, Illinois, U.S.)
  • Eli Lilly and Company (Indianapolis, Indiana, U.S.)
  • Amgen Inc. (Thousand Oaks, California, U.S.)
  • Hoffmann-La Roche Ltd (Basel, Switzerland)
  • Novartis AG (Basel, Switzerland)
  • Sanofi (Paris, France)
  • Pfizer Inc. (Brooklyn, New York, U.S.)
  • Merck and Co., Inc. (Kenilworth, New Jersey, U.S.)
  • GlaxoSmithKline plc (Brentford, U.K)
  • Alcon (Geneva, Switzerland)
  • Other Prominent Player

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/north-america-osteoporosis-treatment-market-104867

Table Of Content :

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Osteoporosis, Key Countries, 2019
    • Technology Advances, Osteoporosis Market
    • New Product Launches, Key Players
    • Key Developments, Mergers, Acquisitions, etc.
    • Impact of Covid-19 on the Market
  • North America Osteoporosis Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast By Drug Class
      • Bisphosphonate
      • Hormone Replacement Therapy
      • Selective Estrogen Receptor Modulator (SERMs)
      • RANK ligand (RANKL) Inhibitor
      • Others
    • Market Analysis, Insights and Forecast By Route of Administration
      • Oral
      • Cardiovascular
    • Market Analysis, Insights and Forecast By Distribution Channel
      • Hospitals Pharmacies
      • Retail Pharmacies and Stores
      • Online Pharmacies
    • Market Analysis, Insights and Forecast By Country
      • U.S.
      • Canada

Toc Continue…

GlobalNorth America Osteoporosis Treatment MarketSegmentation :

By Drug Class

  • Bisphosphonate
  • Hormone Replacement Therapy
  • Selective Estrogen Receptor Modulator (SERMs)
  • RANK ligand (RANKL) Inhibitor
  • Others

By Route of Administration

  • Oral
  • Parenteral

By Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies and Stores
  • Online Pharmacies

By Geography

  • The U.S.
  • Canada

More Trending Topics from Fortune Business Insights :

Hearing Aids Market | 2021 Global Industry Analysis By Covid-19 Impact On Healthcare Sector, Business With Forecast To 2026

Knee Replacement Market | 2021 Global Industry Analysis By Covid-19 Impact On Healthcare Sector, Business With Forecast To 2026

Clear Aligners Market | 2021 Global Industry Analysis By Covid-19 Impact On Healthcare Sector, Business With Forecast To 2026

In-Vitro Diagnostics Market | 2021 Global Industry Analysis By Covid-19 Impact On Healthcare Sector, Business With Forecast To 2026

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email:[email protected]

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit North America Osteoporosis Treatment Market to Reach USD 8.29 Billion by 2027

comtex tracking